Impacts from Cohorts One & Two of the MedTech SuperConnector accelerator programmes
Read our latest newsletter: retrospective on the impact and learnings from cross institutional collaboration
The MedTech SuperConnector is set up and designed to facilitate the early stage development of innovative medical technologies, from devices, diagnostics, and digital healthcare solutions. MTSC will provide participants with the funding, training, mentorship and access to industry partners to help fast-track the translation of their research discoveries.See how it works
Dive into the programme and hear more from the first cohort.
How we are funded
Funded by Research England, MedTech SuperConnector (MTSC) is an initiative from a consortium of eight dynamic London universities with interest in nurturing talent, ideas, and entrepreneurship. MTSC will focus uniquely on a new route for Post-Docs and graduate students, to translate medtech discoveries from academic labs into startup companies, proposing more solutions to today’s health challenges.
MedTech SuperConnector partners with GSK Consumer Healthcare in new cohort
MedTech SuperConnector (MTSC) has partnered with GSK’s Consumer Healthcare team…
Newsletter: Connecting Capabilities: retrospective on the impact and learnings from cross institutional collaboration
MedTech SuperConnector Newsletter June 2020 We are excited to be…
Collaborating & Networking on Cohort Three
The Imperial-led medical technology entrepreneurship programme MedTech SuperConnector (MTSC) has…
Connecting Capabilities: Impacts from Cohorts One & Two of the MedTech SuperConnector accelerator programmes
MedTech SuperConnector (MTSC) runs alternating eight and six-month accelerator programmes and…
On target: A clever catheter to track and treat brain diseases
Cohort Three participant Riccardo Secoli recent feature by Imperial College…